Heather A Arnett

age ~49

from Seattle, WA

Get Report

Connected to:

Heather Arnett Phones & Addresses

3029 25Th Ave W, Seattle, WA 98199
San Mateo, CA
Brookline, MA
700 Bolinwood Dr, Chapel Hill, NC 27514 • 919 942-5760
Frankfort, KY
Marblehead, MA

Work

Company:

Numedii
Sep 2018
Position:

Vice president research

Education

School / High School:

Harvard Medical School
2002 to 2004

Skills

Biotechnology • Immunology • Drug Discovery • Life Sciences • Molecular Biology • Cell Culture • Cell Biology • Lifesciences • Biochemistry • Biopharmaceuticals • In Vivo • Assay Development • Drug Development • Cancer • Antibodies • Cell • Pharmaceutical Industry

Industries

Biotechnology

License Records

Heather Ann Arnett

License #:

58502 - Expired

Category:

Nursing Support

Issued Date:

Apr 10, 2007

Effective Date:

Aug 5, 2009

Expiration Date:

Apr 10, 2010

Type:

Medication Aide

Heather Ann Arnett

License #:

63173 - Expired

Category:

Nursing Support

Issued Date:

Aug 5, 2009

Effective Date:

Aug 15, 2013

Expiration Date:

Aug 5, 2013

Type:

Medication Aide - 40 Hour

Heather Ann Arnett

License #:

76169 - Expired

Category:

Nursing Support

Issued Date:

Aug 25, 2006

Effective Date:

Dec 29, 2015

Type:

Nurse Aide

Us Patents

Btnl9 Proteins, Nucleic Acids, And Antibodies And Uses Thereof
view source
US Patent:

20130101590, Apr 25, 2013
Filed:

Apr 8, 2011
Appl. No.:

13/640232
Inventors:

Heather A. Arnett - Seattle WA, US
Sabine S. Escobar - Sammamish WA, US
Ryan M. Swanson - Seattle WA, US
Joanne L. Viney - Belmont MA, US
International Classification:

A61K 39/395
C07K 16/18
US Classification:

4241391, 5303873, 536 2353, 43525233, 43525231, 4352523, 43525234, 43525235, 43525421, 43525423, 4352542, 435348, 435365, 435352, 435358, 435369, 435366, 435 691
Abstract:

The invention provides novel BTNL9 proteins, including multimers, fragments, and variants of a human BTNL9 protein. In addition, antibodies that can bind to BTNL9 proteins and nucleic acids encoding BTNL9 proteins are provided. Uses for BTNL9 proteins, and agonists or antagonists thereof, are described.

Resumes

Vice President Research

view source

Location:

100 south Calvert St, Muncie, IN 47303

Industry:

Biotechnology

Work:

Numedii
Vice President Research
Arnett Biosolutions Consulting
Life Sciences and Drug Discovery Consultant
Amgen Feb 2015 - Jun 2017
Director - Inflammation Research
Amgen Mar 2009 - Feb 2015
Principal Scientist
Amgen Mar 2006 - Mar 2009
Senior Scientist

Education:

Harvard Medical School 2002 - 2004
University of North Carolina at Chapel Hill 1997 - 2002
Doctorates, Doctor of Philosophy

Skills:

Biotechnology
Immunology
Drug Discovery
Life Sciences
Molecular Biology
Cell Culture
Cell Biology
Lifesciences
Biochemistry
Biopharmaceuticals
In Vivo
Assay Development
Drug Development
Cancer
Antibodies
Cell
Pharmaceutical Industry